Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
Jin-Deok Joo, Jong Hee Chang, Jeong Hoon Kim, Yong-Kil Hong, Young-Hoon Kim, Chae-Yong Kim
J Korean Neurosurg Soc. 2012;52(2):92-97.   Published online 2012 Aug 31     DOI: https://doi.org/10.3340/jkns.2012.52.2.92
Citations to this article as recorded by Crossref logo
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
Grace S. Ahn, Kihwan Hwang, Tae Min Kim, Chul Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeo
Cancer Research and Treatment.2022; 54(2): 396.     CrossRef
Outcome Analysis and Prognostic Factors in Patients of Glioblastoma Multiforme: An Indonesian Single Institution Experience
Sudibio Sudibio, Jellyca Anton, Handoko Handoko, Tiara Bunga Mayang Permata, Henry Kodrat, Endang Nuryadi, Henry Riyanto Sofyan, Rahmad Mulyadi, Renindra Ananda Aman, Soehartati Gondhowiardjo
Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 1410.     CrossRef
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
Byung Sup Kim, Ho Jun Seol, Do-Hyun Nam, Chul-Kee Park, Il Han Kim, Tae Min Kim, Jeong Hoon Kim, Young Hyun Cho, Sang Min Yoon, Jong Hee Chang, Seok-Gu Kang, Eui Hyun Kim, Chang-Ok Suh, Tae-Young Jung, Kyung-Hwa Lee, Chae-Yong Kim, In Ah Kim, Chang-Ki Hon
Cancer Research and Treatment.2017; 49(1): 193.     CrossRef
Current evidence of temozolomide and bevacizumab in treatment of gliomas
Danop Nanegrungsunk, Wimrak Onchan, Nipon Chattipakorn, Siriporn C. Chattipakorn
Neurological Research.2015; 37(2): 167.     CrossRef
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution
Jin-Deok Joo, Hansol Kim, Young-Hoon Kim, Jung Ho Han, Chae-Yong Kim
Journal of Korean Medical Science.2015; 30(11): 1597.     CrossRef
Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group
Ji Hyun Chang, Chae-Yong Kim, Byung Se Choi, Yu Jung Kim, Jae Sung Kim, In Ah Kim
Journal of Korean Neurosurgical Society.2014; 55(1): 5.     CrossRef